Meet Demeetra At The 5th Annual CRISPR AgBio Congress
The 5th Annual CRISPR AgBio Congress will unite research leaders, molecular biologists, regulatory experts, and product developers across the industry working to translate cutting-edge CRISPR technology into a tangible product.
Read More30th Annual Plant & Animal Genome Conference 2023
PAG30 is the premier and largest Ag genomics meeting in the world. Meet us there to learn how our gene editing tools, Cas-CLOVER nuclease and piggyBac transposase can enable research and commercial product development.
Read More
Protein Engineered Cas-CLOVER Yields 99% Gene Editing Efficiency and Ultra-Low Toxicity
At the 2022 Bioprocessing Summit, Demeetra’s Corey Brizzee presented Cas-CLOVER’s mechanism and newly engineered variants. This proven platform is enabling gene editing with extremely high efficiency and very low cell toxicity. View the presentation below. Learn more about Cas-CLOVER Read our Peer-reviewed Publications Schedule a call with us to learn more.
Read More
Seamlessly Upgrade Your CRISPR Toolbox From Cas9 to Cas-CLOVER™
Over a decade ago, Cas9 came on the scene as the first RNA-guided nuclease, simplifying and expanding the use of gene editing. But now it’s time for an upgrade in performance and economy. Single RNA-guided Cas9 yields high off-target mutation frequencies, which often result in disruptions to product development. The small blunt-ended genomic deletions created…
Read More
Q&A Podcast: Advanced Alternatives to CRISPR/Cas9
The field of genetic engineering is evolving much faster than most would have expected, with new techniques and discoveries announced almost weekly. Recently, Demeetra sponsored an insightful Q&A podcast with Drs. George Church and Eric Ostertag to discuss the exciting field of gene editing, and the new techniques and discoveries at Demeetra. The podcast reviews…
Read More
Gene Editing May Soon Be Rolling in Clover
The early CRISPR-Cas9 gene editing systems didn’t lack for brashness. They quickly set new standards for economy and ease of use. They even seemed to offer high degrees of accuracy and efficiency. But soon, brashness started to show its limits. What was needed in its place was refinement. Possible alternatives to CRISPR-Cas9 included a transposase…
Read MoreThe Annual Bioprocessing Summit 2022
For more than 10 years, The Bioprocessing Summit has been recognized as the premier forum for industry leaders to share the latest research in bioprocessing. Meet our team in Boston to chat about the latest studies or to gain an intimate understanding of our cutting edge gene editing technology.
Read More
The Greatest Gene Editing Technology on the Planet?
As published in GEN Magazine. Cas-CLOVER significantly reduces off-target risk with a paired gRNA, deactivated Cas fusion protein (dCas), and dimeric Clo051 nuclease. A proven technology for cell line development (CLD) and bioprocessing, agriculture, and synthetic biotechnology, Cas-CLOVER also features high efficiency in target cells and organisms coupled with simple and flexible design and technology…
Read More